CTS vs DXCM · P/E 22, rev $541.3M vs P/E 63, rev $2.50B
CTS Corporation (CTS) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
CTS Corporation (CTS) is a electronic components company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported CTS revenue for 2025-12-31 was $541.3M. Net income was $65.3M. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. CTS currently screens at market cap $1.30B and trailing P/E 22.1.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
CTS currently screens at market cap $1.30B and trailing P/E 22.1. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the CTS and DXCM stock pages for the full models.
Not investment advice.